Go Pro

Corient Private Wealth LP Makes New $18.13 Million Investment in Revvity Inc. $RVTY

Revvity logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Corient Private Wealth LP acquired 162,985 Revvity shares during the second quarter, valued at approximately $18.13 million, giving it a 0.15% stake. Institutional investors collectively own 86.65% of the company.
  • Analysts remain cautious, with three Buy ratings and twelve Hold ratings; Revvity has an average consensus rating of Hold and a $108.36 price target.
  • Revvity beat quarterly earnings expectations with $1.41 in EPS versus $1.21 forecast and $729.69 million in revenue, while revenue declined 1.3% year over year. The company also declared a quarterly dividend of $0.07 per share.
  • Interested in Revvity? Here are five stocks we like better.

Corient Private Wealth LP purchased a new position in shares of Revvity Inc. (NYSE:RVTY - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 162,985 shares of the company's stock, valued at approximately $18,133,000. Corient Private Wealth LP owned 0.15% of Revvity as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Ascentis Independent Advisors purchased a new stake in Revvity in the 1st quarter valued at approximately $29,000. CYBER HORNET ETFs LLC acquired a new position in Revvity during the 2nd quarter worth approximately $32,000. MUFG Securities EMEA plc purchased a new position in shares of Revvity during the 2nd quarter worth approximately $34,000. SJS Investment Consulting Inc. raised its stake in shares of Revvity by 5,210.0% during the 1st quarter. SJS Investment Consulting Inc. now owns 531 shares of the company's stock worth $47,000 after buying an additional 521 shares in the last quarter. Finally, Headlands Technologies LLC acquired a new stake in shares of Revvity in the 2nd quarter valued at approximately $49,000. 86.65% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on RVTY shares. Stifel Nicolaus decreased their price target on Revvity from $110.00 to $100.00 and set a "hold" rating on the stock in a research note on Wednesday, May 6th. JPMorgan Chase & Co. cut their price objective on Revvity from $96.00 to $90.00 and set a "neutral" rating for the company in a research report on Wednesday, May 6th. Weiss Ratings raised Revvity from a "sell (d+)" rating to a "hold (c-)" rating in a report on Thursday, July 30th. Sanford C. Bernstein started coverage on shares of Revvity in a research report on Friday, June 26th. They set a "market perform" rating and a $115.00 target price on the stock. Finally, Barclays upped their price target on shares of Revvity from $95.00 to $105.00 and gave the stock an "equal weight" rating in a research note on Thursday, May 7th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $108.36.

View Our Latest Stock Report on RVTY

Revvity Price Performance

Shares of NYSE:RVTY opened at $128.88 on Friday. The business's 50 day simple moving average is $114.09 and its 200-day simple moving average is $101.21. The firm has a market capitalization of $14.38 billion, a price-to-earnings ratio of 61.37, a price-to-earnings-growth ratio of 2.36 and a beta of 1.07. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $130.07.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.20. The firm had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.Revvity's quarterly revenue was down 1.3% on a year-over-year basis. During the same period last year, the business posted $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, equities analysts forecast that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity's dividend payout ratio is 13.33%.

Revvity Profile

(Free Report)

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.

Featured Articles

Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY - Free Report).

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Revvity Right Now?

Before you consider Revvity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.

While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines